Pozo-Laderas Juan Carlos, Pontes-Moreno Antonio, Robles-Arista Juan Carlos, Bautista-Rodriguez M Dolores, Candau-Alvarez Alberto, Caro-Cuenca Maria Teresa, Linares-Sicilia María José
Servicio de Medicina Intensiva, Hospital Universitario Reina Sofía, IMIBIC, CIBERehd, Córdoba, España.
Servicio de Medicina Intensiva, Hospital Universitario Reina Sofía, Córdoba, España.
Rev Iberoam Micol. 2015 Jan-Mar;32(1):46-50. doi: 10.1016/j.riam.2013.03.002. Epub 2013 Apr 11.
Mucormycosis infections are rare in immunocompetent patients, and very few cases of mucormycosis associated with aspergillosis in non-haematological patients have been reported.
A 17-year-old male, immunocompetent and without any previously known risk factors, was admitted to hospital due to a seizure episode 11 days after a motorcycle accident. He had a complicated clinical course as he had a mixed invasive fungal infection with pulmonary involvement due to Aspergillus niger and disseminated mucormycosis due to Rhizomucor pusillus (histopathological and microbiological diagnosis in several non-contiguous sites). He was treated with liposomal amphotericin B for 7 weeks (total cumulative dose >10 g) and required several surgical operations. The patient survived and was discharged from ICU after 5 months and multiple complications.
Treatment with liposomal amphotericin B and aggressive surgical management achieved the eradication of a mixed invasive fungal infection. However, we emphasise the need to maintain a higher level of clinical suspicion and to perform microbiological techniques for early diagnosis of invasive fungal infections in non-immunocompromised patients, in order to prevent spread of the disease and the poor prognosis associated with it.
毛霉病感染在免疫功能正常的患者中较为罕见,非血液系统患者中与曲霉病相关的毛霉病病例报道极少。
一名17岁男性,免疫功能正常,无任何已知危险因素,在摩托车事故11天后因癫痫发作入院。他的临床病程复杂,患有由黑曲霉引起的伴有肺部受累的混合性侵袭性真菌感染以及由少根根霉引起的播散性毛霉病(在几个不连续部位的组织病理学和微生物学诊断)。他接受了脂质体两性霉素B治疗7周(总累积剂量>10 g),并需要多次手术。患者存活,在经历多种并发症后5个月从重症监护病房出院。
脂质体两性霉素B治疗和积极的手术管理实现了对混合性侵袭性真菌感染的根除。然而,我们强调需要保持更高的临床怀疑水平,并对非免疫受损患者进行微生物学技术检查以早期诊断侵袭性真菌感染,以防止疾病传播及其相关的不良预后。